Home › NDC Lookup › RxCUI directory › RxCUI 1046985

Hyoscyamine sulfate 0.125 MG Disintegrating Oral Tablet — RxCUI 1046985

RxNorm drug concept · Semantic clinical drug
RxCUI 1046985 Semantic clinical drug · SCD ● Current RxNorm concept 14 FDA products 14 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1046985
Official nameHyoscyamine sulfate 0.125 MG Disintegrating Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped14
Package NDCs mapped14
Reported Medicaid activity (SDUD)12,463 prescriptions · 39 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Hyoscyamine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
📖 Read our full Hyoscyamine guide →

🕸️ Concept Web — How Hyoscyamine sulfate 0.125 MG Disintegrating Oral... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Hyoscyamine sulfate 0.125 MG Disintegrating Oral Tablet RxCUI 1046985

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Hyoscyamine 153970
    • Hyoscyamine sulfate 1225
  2. Brand names 5

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Anaspaz 769
    • Ed Spaz 352618
    • Nulev 284812
    • Oscimin 1146685
    • Symax 541626
  3. Dose forms 37

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Hyoscyamine Disintegrating Oral Tablet 370665
    • Hyoscyamine sulfate Disintegrating Oral Tablet 2646116
    • Hyoscyamine Disintegrating Oral Product 1294826
    • Hyoscyamine Oral Product 1165278
    • Hyoscyamine Pill 1165279
    • Hyoscyamine sulfate Disintegrating Oral Product 2663241
    • Hyoscyamine sulfate Oral Product 2659505
    • Hyoscyamine sulfate Pill 2661552
    • +29 more in this family
  4. Clinical & branded drugs 11

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Hyoscyamine sulfate 0.125 MG 1046981
    • Hyoscyamine sulfate 0.125 MG Disintegrating Oral Tablet [Anaspaz] 1048056
    • Hyoscyamine sulfate 0.125 MG Disintegrating Oral Tablet [Ed Spaz] 1048058
    • Hyoscyamine sulfate 0.125 MG Disintegrating Oral Tablet [Nulev] 1242705
    • Hyoscyamine sulfate 0.125 MG Disintegrating Oral Tablet [Oscimin] 1146688
    • Hyoscyamine sulfate 0.125 MG Disintegrating Oral Tablet [Symax] 1046986
    • Hyoscyamine sulfate 0.125 MG [Anaspaz] 1048055
    • Hyoscyamine sulfate 0.125 MG [Ed Spaz] 1048057
    • +3 more in this family

Showing up to 8 concepts per family — 23 of 55 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Hyoscyamine sulfate 0.125 MG SCDC · 1046981
  • Hyoscyamine Disintegrating Oral Tablet SCDF · 370665
  • Hyoscyamine sulfate Disintegrating Oral Tablet SCDFP · 2646116
  • Hyoscyamine Disintegrating Oral Product SCDG · 1294826
  • Hyoscyamine Oral Product SCDG · 1165278
  • Hyoscyamine Pill SCDG · 1165279
  • Hyoscyamine sulfate Disintegrating Oral Product SCDGP · 2663241
  • Hyoscyamine sulfate Oral Product SCDGP · 2659505
  • Hyoscyamine sulfate Pill SCDGP · 2661552

Brand-Name Concepts

  • Hyoscyamine sulfate 0.125 MG Disintegrating Oral Tablet [Nulev] SBD · 1242705
  • Hyoscyamine sulfate 0.125 MG Disintegrating Oral Tablet [Anaspaz] SBD · 1048056
  • Hyoscyamine sulfate 0.125 MG Disintegrating Oral Tablet [Ed Spaz] SBD · 1048058
  • Hyoscyamine sulfate 0.125 MG Disintegrating Oral Tablet [Oscimin] SBD · 1146688
  • Hyoscyamine sulfate 0.125 MG Disintegrating Oral Tablet [Symax] SBD · 1046986
  • Hyoscyamine sulfate 0.125 MG [Anaspaz] SBDC · 1048055
  • Hyoscyamine sulfate 0.125 MG [Ed Spaz] SBDC · 1048057
  • Hyoscyamine sulfate 0.125 MG [Nulev] SBDC · 1048070
  • Hyoscyamine sulfate 0.125 MG [Oscimin] SBDC · 1146686
  • Hyoscyamine sulfate 0.125 MG [Symax] SBDC · 1046983

📦 FDA Products & Package NDCs

14 products · 14 package NDCs
14 package NDCs map to RxCUI 1046985 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
39328-0049-10 100 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE, PLASTIC (3932... Hyoscyamine Sulfate Patrin Pharma, Inc. 2024-08-15
42192-0338-01 100 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (42192-338-01) Hyoscyamine Sulfate ODT Acella Pharmaceuticals, LLC 2011-05-19
62135-0511-47 473 mL in 1 BOTTLE (62135-511-47) Hyoscyamine Sulfate Chartwell RX, LLC 2022-07-20
62135-0512-12 120 TABLET in 1 BOTTLE (62135-512-12) Hyoscyamine sulfate Chartwell RX, LLC 2022-11-17
62135-0513-52 20 mL in 1 BOTTLE (62135-513-52) Hyoscyamine sulfate Chartwell RX, LLC 2022-08-01
62135-0858-12 120 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (62135-858-12) Hyoscyamine sulfate Chartwell RX, LLC 2024-09-20
62135-0859-12 120 TABLET in 1 BOTTLE (62135-859-12) Hyoscyamine sulfate Sublingual Chartwell RX, LLC 2024-09-20
62559-0422-01 100 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (62559-422-01) Hyoscyamine Sulfate ANI Pharmaceuticals, Inc. 2024-02-15
63561-0197-01 100 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (63561-0197-1) Hyoscyamine Sulfate Granulation Technology, Inc. 2026-04-16
63629-1030-01 100 TABLET in 1 BOTTLE (63629-1030-1) Hyoscyamine Sulfate Bryant Ranch Prepack 2022-03-08
68220-0118-10 100 TABLET, CHEWABLE in 1 BOTTLE (68220-118-10) NuLev Viatris Specialty LLC 2008-12-01
69367-0679-01 100 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (69367-679-01) Hyoscyamine Sulfate ODT Westminster Pharmaceuticals, LLC 2025-04-02
72162-1941-01 100 TABLET in 1 BOTTLE (72162-1941-1) Hyoscyamine Sulfate Bryant Ranch Prepack 2023-08-31
72789-0563-01 100 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE, PLASTIC (7278... Hyoscyamine Sulfate PD-Rx Pharmaceuticals, Inc. 2026-05-11
Observed labelers: Chartwell RX, LLC (5) · Bryant Ranch Prepack (2) · Acella Pharmaceuticals, LLC (1) · ANI Pharmaceuticals, Inc. (1) · Granulation Technology, Inc. (1) · Patrin Pharma, Inc. (1) · +3 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.